Insights

News
Blog Posts
Whitepapers
Events
Webinars
Case Studies

Latest News

View More
China GACC Revises Filing Rules for Imported Food Importers & Exporters

GACC has simplified filing for imported-food importers and exporters while strengthening port verification, change reporting and ongoing supervision.

November 18, 2026
China GACC Revises Filing Rules for Imported Food Importers & Exporters
Beijing MPA Clarifies Electronic Customs Clearance Pilot for Imported Drugs

Beijing's pilot allows companies to download and print approved import clearance documents digitally, reducing paperwork while maintaining existing regulatory requirements.

November 18, 2026
Beijing MPA Clarifies Electronic Customs Clearance Pilot for Imported Drugs
Two Chinese laboratory professionals check a benchtop blood analyzer as one loads a rack of capped sample tubes.
China Issues GMP Inspection Guidelines for Sterile, Implant, IVD, Denture and Standalone Software Devices

China has introduced GMP inspection guidelines for sterile, implantable, IVD, custom-made denture and standalone software medical devices.

November 16, 2026
China Issues GMP Inspection Guidelines for Sterile, Implant, IVD, Denture and Standalone Software Devices
Two Indian clinicians review a chest X-ray on a tablet, where diagnostic software has flagged an area in one lung.
India Clarifies How Medical Device Software, and AI-Enabled Tools Are Regulated

India’s CDSCO releases final medical device software guidance under MDR 2017, outlining licensing routes, software risk classes, and cybersecurity standards.

November 12, 2026
India Clarifies How Medical Device Software, and AI-Enabled Tools Are Regulated
Singapore Updates GN-15 Medical Device Registration Guidance

Singapore’s HSA has revised GN-15 medical device registration guidance, updating submission templates, SaMD requirements and post-market expectations.

November 12, 2026
Singapore Updates GN-15 Medical Device Registration Guidance
China MARA Releases 7th Edition Veterinary Pharmacopoeia Volume III

Find out which imported veterinary biological products need updated testing, revised registration standards, or regulatory approval before May 2027.

November 3, 2026
China MARA Releases 7th Edition Veterinary Pharmacopoeia Volume III

Latest Blog Posts

View More
China NMPA Medical Device Registration Timeline Calculator

Use our interactive calculator to estimate your China NMPA medical device registration timeline, key milestones, and approval window.

November 17, 2026
China NMPA Medical Device Registration Timeline Calculator
Timeline Generator: China NMPA Cosmetics Registration & Filing

Answer a few quick questions and get an estimated timeline for registering/filing your cosmetics in China.

November 17, 2026
Timeline Generator: China NMPA Cosmetics Registration & Filing
Do You Need a China Medical Device Clinical Trial? [Quick Check]

Answer a few quick questions and get a preliminary assessment of whether your medical device requires a China clinical trial for NMPA registration.

November 17, 2026
Do You Need a China Medical Device Clinical Trial? [Quick Check]
Timeline Generator: China NMPA New Cosmetics Ingredients Registration & Filing Timeline Generator

How long will it take to get your new cosmetic ingredient approved in China? Use our interactive calculator to estimate your registration or filing timeline and key milestones.

November 17, 2026
Timeline Generator: China NMPA New Cosmetics Ingredients Registration & Filing Timeline Generator
How the Indonesia Halal Certification Process Works (SIHALAL): A Guide to the SHLN & Regular Certification Pathways
5-Step Guide to the GBA Connect Scheme for Medical Manufacturers

Discover how overseas medical companies can access China early via the GBA Connect Pathway, with a 5-step process and hospital coordination tips.

5-Step Guide to the GBA Connect Scheme for Medical Manufacturers

Latest Whitepapers

View More
China NMPA Approval of Medical Devices Whitepaper

Understand the China NMPA medical device approval processes, regulatory pathways, and clinical requirements.

September 28, 2026
China NMPA Approval of Medical Devices Whitepaper
China SELO Manufacturer License (CML) Whitepaper

Learn how the China Manufacturer License (CML) applies to pressure vessels, boilers, and special equipment approvals.

April 18, 2026
China SELO Manufacturer License (CML) Whitepaper
China Compulsory & Voluntary Certification Whitepaper

Explore China’s product safety certification system, testing requirements, certification procedures, and compliance obligations.

April 18, 2026
China Compulsory & Voluntary Certification Whitepaper
‍China SAMR Approval of Health Food & Supplements Whitepaper

Understand SAMR's filing and registration pathways, regulatory requirements, testing obligations, and compliance rules for health foods and supplements.

April 18, 2026
‍China SAMR Approval of Health Food & Supplements Whitepaper

Latest Events

View More
Cisema Will Present at MEDICA 2026: AI, Data & Device Regulation in China

Meet Cisema at MEDICA 2026 as Hamish King and Shouzheng Tan discuss China’s latest rules for AI, data, medical devices, IVDs and digital health.

November 16-19, 2026
Cisema to Present at CMEF Autumn Beijing 2026: ASEAN — A Medical Device Market Importing Over $19 Billion Annually

Meet Cisema at CMEF Autumn Beijing 2026 as Shouzheng Tan presents a compliance strategy for entering ASEAN’s growing medical device market.

October 21–24, 2026
Cisema Will Present at Cosmoprof Asia 2026: Global Market Access, China & Beyond

Join Cisema at Cosmoprof Asia 2026 as CEO Hamish King shares practical insights into cosmetics market access, regulatory strategy and expansion across China and Asia Pacific

November 11, 2026
Cisema Will Present at RAPS Convergence 2026: Navigating Medtech & Pharma Regulations in China

Cisema presented critical China NMPA regulatory updates for medtech & pharma at RAPS Convergence 2026.

September 14–17, 2026
Cisema at 2026 CIFIT Hong Kong Pavilion: Pharmaceutical & Medical Device Regulation in Hong Kong & Southeast Asia

Cisema’s Jacky Li presented at CIFIT 2026 on navigating pharmaceutical and medical device regulations across Hong Kong and Southeast Asia.

September 8–11, 2026
Cisema at ARCS Annual Conference 2026: China & Hong Kong Device Registration

Hamish King presents updates and practical guidance on China and Hong Kong medical device and IVD registrations at the ARCS Annual Conference 2026 in Sydney.

June 10-12, 2026
Promotional webinar banner from Cisema about China and Hong Kong medical device and IVD registrations, showing a gloved laboratory professional using a pipette to add liquid to a rapid diagnostic test cassette beside a petri dish. The graphic highlights re
Cisema Presented on China NMPA Approval Pathways & GBA Opportunities During Hong Kong Healthcare Week

The presentation covered medical product registration in China, Greater Bay Area initiatives, and Hainan policy developments.

May 13, 2026
Cisema at Asia Summit on Global Health 2026

Cisema attended the Asia Summit on Global Health 2026 in Hong Kong, where healthcare leaders discussed the future of healthcare across Asia.

May 11-12, 2026
Hong Kong Chief Executive John KC Lee Speaks at ASGH 2026
Cisema at RAPS Euro Convergence 2026: Drug/Combination Registration Across EU, China & US

Meet Cisema at RAPS Euro Convergence 2026 in Lisbon and learn about regulatory pathways for drug and combination product development across the EU, China, and the US.

May 5-8, 2026
Detailed: Event announcement banner from Cisema promoting attendance at RAPS Euro Convergence in Lisbon, featuring a cityscape of Lisbon, Portugal with warm sunset lighting. The graphic includes headshots of Hamish King (CEO) and Stefanie Fasshauer (Busine
Cisema to Present at PharmaSynergy-RX 2026 – China: Understanding the System Behind the Market

Join Stefanie Fasshauer’s session on China’s pharmaceutical regulatory system at PharmaSynergy-RX 2026

February 5-6, 2026
Cisema presentation banner on understanding China’s life sciences market system, featuring Stefanie Fasshauer and biotech cell imagery.
Cisema Will Present at MEDICA 2025: Exploring the Future of MedTech Across Asia Pacific

Join Cisema at MEDICA 2025 in Düsseldorf to discover opportunities across Asia Pacific’s regulatory and market landscape.

November 17-20, 2025
Cisema banner announcing presentation at MEDICA 2025 with Hamish King and Shouzheng Tan, featuring robotic medical device technology.
Cisema Will Present at Cosmoprof Asia 2025: Breaking into China’s Cosmetics Market

Join Cisema at Cosmoprof Asia 2025 in Hong Kong to gain expert perspectives on navigating China’s cosmetics regulatory landscape.

November 11-14, 2025
Cisema panel banner on entering China’s cosmetics market at Cosmoprof Asia, featuring Hamish King and skincare product imagery.
Cisema at the Hong Kong International Medical Device Regulatory Forum

Cisema joined the Hong Kong International Medical Device Regulatory Forum to discuss AI-driven medical device regulation, clinical validation, and upcoming Hong Kong medical device legislation.

May 28, 2025
Cisema at the Asia Summit on Global Health (ASGH) 2025 – Hong Kong

Cisema joined the Asia Summit on Global Health in Hong Kong to discuss healthcare innovation, investment, and new regulatory pathways connecting Hong Kong and China’s Greater Bay Area.

May 26–27, 2025
Cisema at RAPS Euro Convergence 2025 – Brussels

Cisema joined RAPS Euro Convergence 2025 in Brussels, sharing insights on China’s regulatory reforms, global compliance strategies, and the growing role of AI in regulatory and clinical development.

May 13–16, 2025
Previous
Previous

Latest Webinars

View More
Free Webinar: How to Obtain the SELO License for the Chinese Market: Regulations and Procedures

Learn how to navigate China's SELO licensing requirements, avoid regulatory setbacks and get your products ready for export.

December, 1, 2026 | 2:00pm CET
Free Webinar: How to Obtain the SELO License for the Chinese Market: Regulations and Procedures
Clinical Strategy China (NMPA): From MDR Approval to Market Access

Join Nick Guo and Zimo Chu from Cisema for a two-day webinar on using MDR clinical data to support China NMPA approval.

September 23-24, 2026 | 09:00–11:30am CEST
Clinical Strategy China (NMPA): From MDR Approval to Market Access
BPI Update Digital: China Pharma 2026 Regulatory Trends & Emerging Developments

Cisema’s Stefanie Fasshauer shared insights into recent NMPA reforms, drug registration, compliance requirements, and emerging trends shaping China’s pharmaceutical landscape.

September 8, 2026 ! 10:00–11:30am
BPI Update Digital: China Pharma 2026 Regulatory Trends & Emerging Developments
Free Webinar: Southeast Asia Market Entry: Regulatory Strategy for Medical Devices & SaMD

Plan your medical device or SaMD expansion in Southeast Asia with practical guidance on ASEAN regulations, market entry pathways, timelines, and approval strategies.

June 2, 2026 | 10:00–10:45am CEST
Free Webinar: Southeast Asia Market Entry: Regulatory Strategy for Medical Devices & SaMD

Case Studies

Read about how we work with clients to find solutions, bringing together deep industry knowledge with leading talent.

View More
August 7, 2026

Filing a Device-Linked Anti-Ageing Cream in China | Global Skincare Brand Case Study

Learn how Cisema enabled a global skincare brand to navigate China’s cosmetics regulations to support an anti-ageing cream designed for use with a beauty device.

Learn More
June 23, 2026

China Manufacture License Renewal for Level A2 Pressure Vessels

Cisema supported Inox Torres Group in successfully renewing its China SELO license for Level A2 pressure vessels through expert audit preparation and regulatory guidance.

Learn More
Previous
Previous

Get in Touch with Our Consultants

And discover how we can support you.

Talk to an Expert